Clonal priming of human lymphocytes: Specificity and cross-reactivity of cellular immune reactions (Q39433093)
scientific article published on April 23, 1977
Language:
Current Data About Clonal priming of human lymphocytes: Specificity and cross-reactivity of cellular immune reactions
(P31) (Q13442814)
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

(P304) 875-877
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

(P407) (Q1860)

(P433) 8017
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

(P478) 1
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

(P577) Friday, April 1, 1977
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

Saturday, April 23, 1977
(P248)
(P698) 67286
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=67286
(P813) Wednesday, April 13, 2022

(P921) (Q128711)
(P248)
(P698) 67286
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A67286
(P813) Wednesday, April 13, 2022

(Q1760689)
(P248)
(P698) 67286
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A67286
(P813) Wednesday, April 13, 2022

(Q189146)
(P248)
(P698) 67286
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A67286
(P813) Wednesday, April 13, 2022

(P953) https://api.elsevier.com/content/article/PII:S0140673677912004?httpAccept=text/xml
(P248)
(P356) 10.1016/S0140-6736(77)91200-4
(P854) https://api.crossref.org/works/10.1016/S0140-6736(77)91200-4
(P813) Wednesday, April 13, 2022

https://api.elsevier.com/content/article/PII:S0140673677912004?httpAccept=text/plain
(P248)
(P356) 10.1016/S0140-6736(77)91200-4
(P854) https://api.crossref.org/works/10.1016/S0140-6736(77)91200-4
(P813) Wednesday, April 13, 2022

(P1433) (Q939416)
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

(P1476) "Clonal priming of human lymphocytes: Specificity and cross-reactivity of cellular immune reactions" (language: en)
(P248)
(P698) 67286
(P813) Monday, September 11, 2017

(P2093) W. R. Levis
(P1545) 1
(P248)
(P698) 67286
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A67286
(P813) Wednesday, April 13, 2022

A. M. Datiner
(P1545) 2
(P248)
(P698) 67286
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A67286
(P813) Wednesday, April 13, 2022

(P2860) (Q66945691)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q34509248)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q47950044)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q66942808)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q35012164)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q43594210)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q39737313)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q39368563)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q70004581)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

(Q70017187)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2991200-4
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on April 23, 1977

External Links
(P356) 10.1016/S0140-6736(77)91200-4
(P698) 67286
(P8608) release_rmmek55z2bfifpmixuv3fmfwbe